Anti-CD38 antibodies for treatment of acute myeloid leukemia

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10793630
APP PUB NO 20160222106A1
SERIAL NO

14956890

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to methods of treatment of acute myeloid leukemia with anti-CD38 antibodies.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JANSSEN BIOTECH INC800/850 RIDGEVIEW DRIVE HORSHAM PA 19044

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Danet-Desnoyers, Gwenn Philadelphia, US 2 32
Dos, Santos Cedric San Bruno, US 2 32
Doshi, Parul Chester Springs, US 14 245
Sasser, Amy Doylestown, US 12 160
Shan, Xiaochuan Philadelphia, US 4 36

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 6, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 6, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00